NCT04407312View on ClinicalTrials.gov

Cilostazol and Endothelial Progenitor Cell

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

July 31, 2020

Conditions
Myocardial Infarction, Acute
Interventions
DRUG

Cilostazol Tablets

Cilostazol-SR, capsule, 200mg, once daily, 30 days.

DRUG

placebo

Placebo, tablet, 200mg, once daily, 30 days.

DRUG

Aspirin

Astrix, capsule,100mg, once daily, 30 days.

DRUG

Clopidogrel

Plavix, tablet, 75mg, once daily, 30 days.

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Gyeongsang National University Hospital

OTHER